Cheyenne, Wyoming , June 13, 2016 (GLOBE NEWSWIRE) -- MedX Holdings, Inc. (OTC PINK: MEDH) today announced that we have acquired MedX Pharmaceuticals as a wholly-owned subsidiary. MedX Pharmaceuticals, Inc. is an Alabama corporation which is licensed to do business in the state of Alabama. Our office is located at 750 Lakeside Drive, Suite A, Mobile, Alabama 33396. We have 3,114 sq ft of office space which includes 3 executive offices, a conference room and 1 fully climate controlled storage for our diverse pharmaceuticals. In addition, it also has 1,500 sq. ft. of additional warehouse space for us to grow for a total of 4,612 sq ft
Ms. Roberton, CEO commented: “We only had an “idea” a mere 2 months ago. Now we have an agreement with a premier FDA Approved Manufacturer, a sales-proven sales team standing by, over 400 pharmacies as potential vetted clients, a subsidiary to fully manage our pharmaceutical division, and a warehouse/office that is a stand- alone turnkey building ideally situated right on I-65 N and just 1.5 mile to I-10 E/W in Mobile, Alabama. Now all we need is a license – I’m amazed at our progress in such little time”.
MedX Holdings, Inc. is a publicly trading holding company utilizing a new form of Collaborative Governance. MEDH targets the acquisitions of undervalued, turnaround medical related businesses. In addition, MedX Pharmaceuticals, a wholly-owned subsidiary of MEDH is newly emerging as dynamic distributor of an array pharmaceutical products.
For more information about MedX Holdings, Inc., call (877) 225-0243 or visit our web site www.medxholdings.com is located at 1621 Central Avenue, Cheyenne, WY, USA
Safe-Harbor Statement under the Private Securities Litigation Reform Act of 1995: This press release may contain forward-looking information within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended (the Exchange Act), including all statements that are not statements of historical fact regarding the intent, belief or current expectations of the company, its directors or its officers with respect to, among other things: (i) the company’s financing plans; (ii) trends affecting the company’s financial condition or results of operations; (iii) the company’s growth strategy and operating strategy; and (iv) the declaration and payment of dividends. The words “may,” “would,” “will,” “expect,” “estimate,” “anticipate,” “believe,” “intend” and similar expressions and variations thereof are intended to identify forward-looking statements. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond the company’s ability to control, and that actual results may differ materially from those projected in the forward-looking statements as a result of various factors including the risk disclosed in the company’s Forms 10-K and 10-Q filed with the SEC.
Phone: 877-225-0243 firstname.lastname@example.org
Source:MedX Holdings, Inc.